Sign In

Login

Password

Forgot Password ? Sign Up

GSK (Pharmaunternehmen) (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "GSK (Pharmaunternehmen)" in German language version.

refsWebsite
Global rank German rank
10gsk.com
low place
low place
3web.archive.org
1st place
1st place
2apotheke-adhoc.de
low place
1,805th place
2doi.org
2nd place
3rd place
2nih.gov
4th place
7th place
1handelsblatt.com
1,065th place
65th place
1glaxosmithkline.de
low place
low place
1consorsbank.de
low place
low place
1bbc.co.uk
8th place
37th place
1freace.de
low place
low place
1bloomberg.com
99th place
323rd place
1depression-heute.de
low place
low place
1gsk-clinicalstudyregister.com
low place
low place
1finanznachrichten.de
9,466th place
820th place
1boersennews.de
low place
5,524th place
1redirecter.toolforge.org
33rd place
2nd place
1senate.gov
758th place
1,627th place
1spiegel.de
66th place
4th place
1theguardian.com
12th place
25th place
1orf.at
418th place
22nd place
1londonstockexchange.com
low place
low place
1gskpro.com
low place
low place
1innovations-report.de
low place
3,111th place

apotheke-adhoc.de

bbc.co.uk

news.bbc.co.uk

bloomberg.com

boersennews.de

consorsbank.de

wissen.consorsbank.de

depression-heute.de

doi.org

  • S. E Nissen: The rise and fall of rosiglitazone. In: European Heart Journal. 31. Jahrgang, Nr. 7, April 2010, S. 773–6, doi:10.1093/eurheartj/ehq016, PMID 20154334.
  • T. F. Lüscher, U. Landmesser, F. Ruschitzka: Standing firm–the European Heart Journal, scientific controversies and the industry. In: European Heart Journal. 31. Jahrgang, Nr. 10, Mai 2010, S. 1157–8, doi:10.1093/eurheartj/ehq127, PMID 20418345 (freepdfhosting.com (Memento des Originals vom 27. Februar 2012 im Internet Archive)).

finanznachrichten.de

freace.de

glaxosmithkline.de

gsk-clinicalstudyregister.com

gsk.com

gskpro.com

  • Produkte. Abgerufen am 16. Oktober 2024 (deutsch).

handelsblatt.com

  • Voltaren, Fenistil, Sensodyne: Novartis steigt bei Joint-Venture aus – und erhält 13 Milliarden Dollar. 27. März 2018 (handelsblatt.com [abgerufen am 27. März 2018]).

innovations-report.de

londonstockexchange.com

nih.gov

ncbi.nlm.nih.gov

  • S. E Nissen: The rise and fall of rosiglitazone. In: European Heart Journal. 31. Jahrgang, Nr. 7, April 2010, S. 773–6, doi:10.1093/eurheartj/ehq016, PMID 20154334.
  • T. F. Lüscher, U. Landmesser, F. Ruschitzka: Standing firm–the European Heart Journal, scientific controversies and the industry. In: European Heart Journal. 31. Jahrgang, Nr. 10, Mai 2010, S. 1157–8, doi:10.1093/eurheartj/ehq127, PMID 20418345 (freepdfhosting.com (Memento des Originals vom 27. Februar 2012 im Internet Archive)).

orf.at

redirecter.toolforge.org

  • T. F. Lüscher, U. Landmesser, F. Ruschitzka: Standing firm–the European Heart Journal, scientific controversies and the industry. In: European Heart Journal. 31. Jahrgang, Nr. 10, Mai 2010, S. 1157–8, doi:10.1093/eurheartj/ehq127, PMID 20418345 (freepdfhosting.com (Memento des Originals vom 27. Februar 2012 im Internet Archive)).

senate.gov

finance.senate.gov

spiegel.de

theguardian.com

  • China accuses British GlaxoSmithKline executive in bribery case. In: Guardian. 14. Mai 2014, abgerufen am 14. Mai 2014 (englisch): „Chinese police have accused a British executive in drugs maker GlaxoSmithKline's China unit of ordering his salespeople to bribe doctors and hospital officials to use the company's products. Wednesday's announcement marks the first time a foreign employee in China of British-based GSK has been accused in connection with the bribery allegations against the company.“

web.archive.org